Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
inflammatory diseases
Research
Nobel winner turns rogue T cells into their own treatment
By tweaking signaling pathways in the lab, disease-causing T cells were converted into targeted regulatory T cells that suppress inflammation.
Darren Incorvaia
Oct 23, 2025 10:35am
British biotech elevates with $70M and midstage arthritis asset
Oct 21, 2025 7:01pm
How Nobel-winning cells could become a 'universal drug'
Oct 21, 2025 2:00pm
Expedition resupplies for ph. 2 COPD voyage with $165M series A
Oct 9, 2025 9:50am
MoonLake stock sinks as high placebo rate eclipses ph. 3 results
Sep 29, 2025 8:05am
Odyssey saga continues with $213M series D
Sep 10, 2025 8:00am